Amundi’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,058
| Closed | -$95.7K | – | 2055 |
|
|
2025
Q1 | $95.7K | Buy |
2,058
+25
| +1% | +$1.16K | ﹤0.01% | 1752 |
|
|
2024
Q4 | $76.5K | Hold |
2,033
| – | – | ﹤0.01% | 1815 |
|
|
2024
Q3 | $89.4K | Sell |
2,033
-674
| -25% | -$29.6K | ﹤0.01% | 1788 |
|
|
2024
Q2 | $93.4K | Hold |
2,707
| – | – | ﹤0.01% | 1715 |
|
|
2024
Q1 | $68.3K | Buy |
2,707
+675
| +33% | +$17K | ﹤0.01% | 1813 |
|
|
2023
Q4 | $51.6K | Sell |
2,032
-1,687
| -45% | -$42.8K | ﹤0.01% | 1883 |
|
|
2023
Q3 | $57.4K | Hold |
3,719
| – | – | ﹤0.01% | 1847 |
|
|
2023
Q2 | $83K | Buy |
+3,719
| New | +$83K | ﹤0.01% | 1804 |
|
|
2022
Q2 | – | Sell |
-3,855
| Closed | -$98K | – | 1692 |
|
|
2022
Q1 | $98K | Sell |
3,855
-198
| -5% | -$5.03K | ﹤0.01% | 1469 |
|
|
2021
Q4 | $141K | Buy |
+4,053
| New | +$141K | ﹤0.01% | 1523 |
|